TLR4 and cancer: To investigate whether and how trained immunity was formed during cancer development, we established a subcutaneous Lewis lung carcinoma (LLC) model in mice that were devoid of TLR4, the prototypic pattern-recognition receptor for both pathogen and damage-associated signals.